PatientFi has launched PRIVI, an aesthetics membership platform that enables patients to pay for an annual recurring treatment plan on a monthly basis through their preferred aesthetic provider.
Aesthetic practices can use PRIVI’s cloud-based portal to build personalized beauty memberships that can be comprised of neurotoxin, filler, skincare, body treatments, and more —all on a monthly membership plan. Instead of facing large bills each time they visit their aesthetic provider, patients just pay monthly for an annual treatment plan, customized to them.
The global non-invasive aesthetic treatment market is expected to grow from $43.87 billion in 2021 to $49.32 billion in 2022 and is expected to reach $85.64 billion in 2026. Today, there are nearly 40,000 medical providers in the U.S. who offer non-invasive treatments to patients. The largest barrier to continued growth is patient affordability and access to qualified providers who can deliver desired outcomes.
“PatientFi has become a leading provider of payment solutions for large ticket aesthetic procedures, so PRIVI was a natural extension for us,” says Todd Watts, CEO and co-founder of PatientFi. “PRIVI is solving some of the longest standing pain points for the non-invasive aesthetic market—affordability, scheduling, and treatment compliance. PRIVI offers practices a new way to increase business and retain it while dramatically increasing accessibility for patients.”
Key elements of PRIVI include:
- Streamlined payments: Enables participating providers to receive payment in full when treatments are rendered, while patients benefit from the convenience of a monthly membership payment.
- Auto reminders and scheduling: Delivers high patient retention with scheduling tools and automatic reminders to keep patients coming back for ongoing, regular treatments.
- Customized user experience: Offers functionality to customize the membership experience to a practice’s brand and offerings—complete with incentive add-ons and rewards to attract more patients to the membership.